These results help clarifying the neuroprotective phenotype recently associated to Rab10 polymorphisms in Alzheimer’s disease and provide a new therapeutic target to halt neurodegeneration. This evidence concerns the gene RAB10 and early-onset autosomal dominant Alzheimer disease.